amsacrine has been researched along with Urinary Bladder Neoplasms in 6 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "But amsacrine has been forgotten in clinical studies of transitional cell carcinoma of the urinary bladder." | 2.70 | Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: a phase-II study. ( Jelíc, S; Nikolíc-Tomasevíc, Z; Popov, I; Radosavljevíc, D, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedell, GH | 1 |
| Natale, RB | 1 |
| Yagoda, A | 1 |
| Blumenreich, MS | 1 |
| Watson, RC | 1 |
| Trump, DL | 1 |
| Loening, S | 1 |
| Ahmed, SW | 1 |
| Wajsman, Z | 1 |
| Popov, I | 1 |
| Jelíc, S | 1 |
| Radosavljevíc, D | 1 |
| Nikolíc-Tomasevíc, Z | 1 |
| Fry, AM | 1 |
| Chresta, CM | 1 |
| Davies, SM | 1 |
| Walker, MC | 1 |
| Harris, AL | 1 |
| Hartley, JA | 1 |
| Masters, JR | 1 |
| Hickson, ID | 1 |
| Al-Sarraf, M | 1 |
| Frank, J | 1 |
| Smith, JA | 1 |
| O'Bryan, RM | 1 |
| Costanzi, JJ | 1 |
| Stephens, RL | 1 |
| Caraveo, J | 1 |
| Crawford, ED | 1 |
3 trials available for amsacrine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
Topics: Adult; Aminoacridines; Amsacrine; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Ci | 1983 |
Amsacrine and cisplatin in poor prognosis patients with metastatic transitional cell carcinoma of the urothelium: a phase-II study.
Topics: Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell | 2001 |
Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
Topics: Aged; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transiti | 1985 |
3 other studies available for amsacrine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Topics: Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leuk | 1983 |
Phase II study of amsacrine (AMSA) in previously treated patients with advanced transitional cell carcinoma of the urothelium: a National Bladder Cancer Collaborative Group A study.
Topics: Aminoacridines; Amsacrine; Carcinoma, Transitional Cell; Drug Evaluation; Epithelium; Humans; Kidney | 1983 |
Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines.
Topics: Amsacrine; Blotting, Western; Cell Death; Cross-Linking Reagents; DNA Damage; DNA Topoisomerases, Ty | 1991 |